About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Y
The Gut Microbiota, Hepatic Inflamation, and Carcinogenesis
By
Yu-Jui Yvonne Wan
128 views
December 13, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
07:27
Ardelyx
Patient Cases: Making Treatment Decisions in IBS-C
Feat.
D. M. Brenner
Featured Video
06:42
Ardelyx
Clinical Experience With an IBS-C Treatment Option
Feat.
J. Shah
Related Content
AUTOPLAY
ON
18:46
Houston Methodist Hospital
MAFLD: What Is It?
Feat.
D. Victor
65:16
MicrobeTV
Persistent Viral Infections: Mechanisms, Consequences, and Examples
Feat.
V. Racaniello
43:23
MedNews Week
Best Practices In Managing NAFLD / NASH
Feat.
D. Bernstein
58:00
West Virginia State Rheumatology Society
2022 Updates on the Management of Lupus Nephritis
Feat.
M. Petri
32:04
Douglas Drossman
Neuromodulators: Making the Right Choice for Your Patient
38:47
UPMC
The Fatty Liver Disease Epidemic
Feat.
M. Klinge
48:59
Northwestern Medicine Gastroenterology
Cutting Edge Diagnostics and Treatment for NAFLD
Feat.
M. E. Rinella,
L. Van Wagner
27:35
Yale School of Medicine
Fatty Liver Disease: When to Refer?
27:34
Cleveland Clinic Neurological Institute
Gut-Brain Axis & Migraine
Feat.
S. Biswas
25:53
Houston Methodist Hospital
Non-Alcoholic Fatty Liver Disease: Where Are We in 2023?
Feat.
N. Gunn
24:30
Scripps Health
Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
Feat.
J. Au
23:28
ACG 2023 Conference Coverage
Moderation of the Microbiome and C. difficile Infection: Have We Fin…
Feat.
P. Feuerstadt
22:23
Pennsylvania Society of Gastroenterology
Updates on Management of NASH
Feat.
T. Singh
33:22
Michigan Medicine
Hepatitis B, C, and D Cases
Feat.
A. Suk-Fong Lok
31:41
LearnSkin
Acne, Rosacea, and Hidradenitis Suppurativa: Diagnosis and Management
Feat.
R. Sivamani
24:52
Paul Feuerstadt
A Clinician's Guide to the Basics of the Microbiota and FMT for…
23:50
Stanford Medicine
Debate: Horizons for Effective Microbial Therapeutics for GI Disease…
Feat.
S. Spencer,
A. Gabrielle Cheng
26:11
Scripps Health
New Treatments of Nonalcoholic Steatohepatitis (NASH): An Update on …
Feat.
J. Frias
55:03
University of Colorado Department of Medicine
Liver Transplantation Evaluation
Feat.
A. Kalra
22:31
University of California, Irvine (UCI) Health 14th Annual Orange County Symposium for Cardiovascular Disease Prevention
Non-Alcoholic Fatty Liver Disease and Cardiovascular Risks: A Scient…
Feat.
P. Duell
